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Abstract
We study the problem of learning personalized decision policies from observational
data while accounting for possible unobserved confounding in the data-generating
process. Previous approaches, which assume unconfoundedness, i.e., that no unobserved
confounders affect both the treatment assignment as well as outcome, can lead to
policies that actually introduce significant harm rather then benefit due to overeager
intervention when some unobserved confounding is present, as is actually the case in
most applications dealing with observational data. Instead, we calibrate policy learning
for realistic violations of this unverifiable assumption with uncertainty sets motivated
by sensitivity analysis in causal inference. Our framework for confounding-robust policy
improvement optimizes the minimax regret of a candidate policy against a baseline
standard-of-care policy over an uncertainty set for propensity weights. We prove that if
the uncertainty set is well-specified, our robust policy, when applied in practice, will
do no worse than the baseline and improve upon it if possible. We characterize the
adversarial optimization subproblem and use efficient algorithmic solutions to optimize
over parametrized spaces of decision policies such as logistic treatment assignment and
decision trees. We assess our methods on synthetic data and on a large clinical trial of
acute ischaemic stroke treatment, demonstrating that hidden confounding can hinder
existing policy learning approaches and lead to unwarranted harm, while our robust
approach guarantees safety and focuses on well-evidenced improvement, a necessity
for making personalized treatment policies learned from observational data reliable in
practice.
History: First version: May 22, 2018. This version: June 27, 2018.
1 Introduction
The problem of learning personalized decision policies to study “what works and for whom”
in areas such as medicine, e-commerce, and civics often endeavors to draw insights from
increasingly rich and plentiful observational data, such as electronic medical records (EMRs),
since data from randomized controlled experiments may be scarce, costly, or unethical to
⇤kallus@cornell.edu
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acquire. A variety of methods have been proposed to address the corresponding problem
of policy learning from observational data (Beygelzimer and Langford 2009, Dudik et al.
2014, Kallus 2017a,b, Kallus and Zhou 2018, Kitagawa and Tetenov 2018, Wager and Athey
2017a). These methods, as well as approaches to predict individual-level causal effects from
observational data (Künzel et al. 2017, Nie and Wager 2017, Shalit et al. 2017, Wager and
Athey 2017b), operate under the controversial assumption of unconfoundedness, which requires
that the data are sufficiently informative such that no confounders that jointly affect treatment
assignment and individual response are unobserved (Rubin 1974), effectively requiring that
assignment is as if at random once we control for observables. This key assumption may
be always made to hold ex ante by directly controlling the treatment assignment policy
as in a randomized controlled experiment, but in other domains of key interest such as
personalized medicine where EMRs are increasingly being analyzed ex post, unconfoundedness
is an assumption that may never truly fully hold in fact.
Assuming unconfoundedness, also called ignorability, conditional exogeneity, or selection
on observables, is controversial because it is fundamentally unverifiable since the counterfactual
distribution is never identified from the data (Imbens and Rubin 2015). Thus, insights from
observational studies, which passively study treatment-outcome data without intervening
on treatment, are always vulnerable to this fundamental critique. For example, studying
drug efficacy by assessing outcomes of those prescribed the drug during the course of normal
clinical practice may make a drug look less clinically effective if those who were prescribed
the drug were sicker to begin with and therefore would have had worse outcomes regardless.
Conversely, if the drug was correctly prescribed only to the patients who would most benefit
from it, it may make the drug appear to be falsely effective for all patients. These issues
can potentially be alleviated by controlling for more baseline factors that may have affected
treatment choices but they can never really be fully eliminated in practice.
Conclusions drawn from healthcare databases such as claims data are particularly vulner-
able to unobserved confounding because although they record administrative interactions and
diagnostic codes, they are uninformative about medical histories, notes on patient severity,
observations, nor monitoring of clinical outcomes, i.e., the key clinical information which
may drive a physician’s treatment choices. EMRs provide great promise for enabling richer
personalized medicine from observational data because they record the entire patient treat-
ment and diagnostic history, past medical history and comorbidities, as well as fine-grained
information regarding patient response such as vital signs (Hoffman and Williams 2011).
The growing adoption of richer EMRs can both provide higher precision for personalized
treatment and render unconfoundedness more plausible, since the data includes more of the
information regarding patient history and outcomes that informs physician decision-making,
yet unconfoundedness, an ideal stylized assumption, still may never be fully satisfied in
practice.
Because unconfoundedness may fail to hold, existing policy learning methods that operate
under this assumption can lead to personalized decision policies that seek to exploit individual-
level effects that are not really there, may intervene where not necessary, and may in fact
lead to net harm rather than net good. Such dangers constitute obvious impediments to the
use of policy learning to enhance decision making in such sensitive applications as medicine,
public policy, and civics, where reliable and safe algorithms are critical to implementation.
Clearly, a policy that could potentially introduce additional harm, toxicity, or risk to patients
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compared to current standards of care is an unacceptable replacement, and an algorithm that
could potentially give rise to such a policy is unusable in medical and other sensitive settings.
To address this deficiency, in this paper we develop a framework for confounding-robust
policy learning and improvement that can ensure that the personalized decision policy derived
from observational data, which inevitably will have some unobserved confounding, will do
no worse than a current policy such as the current standard of care and, in fact, will do
better if the data can indeed support it. We do so by recognizing and accounting for the
potential confounding in the data and requiring that the learned policy improve upon the
baseline no matter the direction of confounding. Thus, we calibrate personalized decision
policies to address sensitivity to realistic violations of the unconfoundedness assumption. For
the purposes of informing reliable and personalized decision-making that leverages modern
machine learning, our work highlights that statistical point identification of individual-level
causal effects, which previous approaches crucially rely on, may not at all be necessary for
successfully learning effective policies that reliably improve on unpersonalized standards of
care, but accounting for the lack of point identification is necessary.
Functionally, our approach is to optimize a policy to achieve the best worst-case improve-
ment relative to a baseline treatment assignment policy (such as treat all or treat none),
where the improvement is measured using a weighted average of outcomes and weights take
values in an uncertainty set around the nominal inverse propensity weights (IPW). This
generalizes the popular class of IPW-based approaches to policy learning, which optimize an
unbiased estimator for policy value under unconfoundedness (Beygelzimer and Langford 2009,
Kitagawa and Tetenov 2018, Li et al. 2011, Swaminathan and Joachims 2015a,b). Unlike
standard approaches, in our approach the choice of baseline is material and changes the
resulting policy chosen by our method. This framing supports reliable decision-making in
practice, as often a practitioner is seeking evidence of substantial improvement upon the
standard of care or a default option, and/or the intervention under consideration introduces
risk of toxicity or adverse effects and should not be applied without strong evidence.
Our contributions are as follows. We provide a framework for performing policy improve-
ment that is robust in the face of unobserved confounding by using a robust optimization
formulation. Our framework allows for the specification of data-driven uncertainty sets based
on a sensitivity parameter describing a pointwise bound on the odds ratio between true
and observed propensities as well as uncertainty sets with a global budget-of-uncertainty
parameter. We prove a uniform law that leads to an appealing improvement guarantee that
shows that, up to vanishing factors that depend on the complexity of the policy class, our
approach will not do worse than the baseline and, moreover, will do better, as can be easily
validated by simply evaluating the objective value of our optimization problem. Leveraging
the structure of our optimization problem and characterizing the inner subproblem, we provide
a set of efficient algorithms for performing robust policy optimization over parametrized
policy classes and over decision trees. We assess performance on a synthetic example that
illustrates the benefits of our approach and the effect of the uncertainty parameters. We then
study a large clinical dataset on the treatment of acute ischaemic stroke, the results of which
suggest only aspirin and not heparin should be used for treatment. We show how standard
approaches that try to learn more personalized policies for treatment can actually introduce
harm by over-intervening with aggressive heparin treatments and introducing adverse effects,
while our approach avoids this and learns to intervene with aggressive treatments only in
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the most severe cases, leading to a personalized treatment policy that improves upon the
recommended standard of only using aspirin.
We first begin by introducing a case study of the parallel Women’s Health Initiative
(WHI) clinical trial and observational study in order to illustrate how confounding factors can
lead to wide clinical discrepancies in the conclusions from observational data or a randomized
trial. By constructing a synthetic model inspired by this case, we demonstrate how these
confounding factors can detrimentally affect policy learning and what can be gained from
robustness to confounding.
2 Women’s Health Initiative: An illustrative case of the
perils of learning to intervene from confounded data
Hormone replacement therapy (HRT) is an effective treatment strategy for vasomotor symp-
toms of menopause, such as hot flashes and night sweats. The clinical practice of prescribing
HRT in menopause was driven in part by observational epidemiological studies that showed
effective reduction of menopausal vasomotor symptoms as well as a protective benefit against
coronary heart disease (CHD) (Pedersen and Ottesen 2003). The results, however, were later
repudiated by more evidence from the WHI clinical trial. In fact, while the observational
study suggested a protective benefit of HRT against CHD, showing a 40-50% reduction in
CHD incidence, the HRT arm of the clinical trial had to be stopped early due to a dangerously
elevated incidence of CHD (Prentice et al. 2005). After the WHI study, the new evidence
that arose not only dramatically changed the standard of care, spurring an 80% reduction in
the prescription of HRT, but also sparked a broader methodological debate about the clinical
credibility of observational studies (Lawlor et al. 2004).
WHI’s study design included a clinical trial enrolling n = 16,608 women with intact uteri
to study combined estrogen-plus-progestin HRT, a separate clinical trial enrolling n = 10,739
women with prior hysterectomy (without a uterus) to study a regimen of estrogen alone, in
parallel to an observational study of n = 93,726 women.1 The progestin-plus-estrogen arm
was stopped prematurely due to preliminary findings suggesting that significant risks for
increased rates of breast cancer, CHD, stroke, and pulmonary embolism outweighed benefits.
The estrogen-only arm was also stopped shortly afterwards. In the immediate aftermath of
the trial results, researchers proposed differing re-analyses and explanations to reconcile the
different findings from the clinical trial and observational study. Many of the explanations, as
we review below, suggested a variety of confounding factors that led self-selection to obfuscate
the actual isolated risks of the treatment alone. Thus, the case of HRT is a clear example of
an intervention policy learned from observational data that led to unwarranted harm due to
unaccounted-for confounding.
The observational study may have been confounded by plausible, well-recognized confound-
ing phenomena, healthy user bias and confounding by indication, which challenge the validity
of all epidemiological research from observational health databases and which may induce
correlation in either direction between treatment selection and outcomes (Brookhart et al.
1Specifically, estrogens consisted of conjugated equine estrogens (CEE) and progestins of medroxyproges-
terone acetate (MPA).
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2010). Such possible confounding factors arise naturally from the structure of healthcare data
in which physicians determined treatment assignment to manage health outcomes in the first
place. Much discussion attributes confounding in the study to healthy user bias arising from
differing lifestyle factors in the population of women self-selecting into HRT, where lifestyle
factors such as general health-seeking behaviors, such as exercise or maintaining heart-healthy
diets, are correlated with better expected outcomes related to CHD on average. These general
health-seeking and health-promoting behaviors tend to reduce artherosclerotic risk and risk
of CHDs, but are unobserved lifestyle factors that are confounders for self-enrollment into
HRT. Conversely, the study may have also been confounded by indication or severity, where
the presence of clinical activities such as prescription of HRT is correlated with, or indicates,
greater initial symptom severity, which may lead to attenuation in the perceived reduction in
vasomotor symptoms.
On the one hand, the trial suggested serious risks of widespread HRT treatment that
may have been misinformed by confounded observational studies, but on the other, as has
been pointed out only later (Vogel 2017), it also suggested that the risk-benefit consider-
ation was different for older and younger women and that younger women may be safely
treated. Specifically, Manson et al. (2013b), Rossouw et al. (2013) note that while the trial
data definitively provide evidence against the net benefits of HRT (administered via the
WHI-proprietary treatment regimen) for prevention of chronic disease, the evidence from
WHI for a standard HRT regimen of estrogen alone was inconclusive to rule out possible
cardiovascular risk reductions for women treated closer to menopause onset (<10 years) with
prior hysterectomy. This may have been left unnoticed at first because since the trial itself
did not include many younger women for whom treatment could be beneficial.
The time-based heterogeneity of treatment effect may arise from clinical explanations that
estrogen may slow down early artherosclerosis, the formation of plaques in arteries, and have
favorable endothelial effects in women with recent onset in menopause. However, unlike other
options such as statin therapies which help prevent CHD at any age and stage of disease, HRT
may actually worsen already-established plaques and thus increase the frequency of coronary
events (see Manson et al. 2013a, Rossouw et al. 2013). These differing risk profiles were also
observed in the observational study, although the risks may have been underestimated across
the board. For all women, the improvement of vasomotor symptoms was significant, but
ultimately the greater risks of adverse events outweigh the clinical benefits for older women.
Modern clinical guidelines, included in Bakour and Williamson (2015), recognize that “when
HRT is individually tailored women gain maximum advantages and the risks are minimised.”
Therefore, the clinically relevant policy learning question is determining the optimal
tailoring of targeted treatments such that the clinical benefits of HRT do not also incur
substantial increase in risk of CHD and other adverse events. Specifically, consider the
situation faced originally when only observational data were available. Recognizing the
potential presence of confounding, how could one analyze the data to infer a targeted
treatment policy that would not introduce any additional harm relative to never treating
with HRT, while benefiting the individuals that could truly benefit from HRT? This is the
question we explore next in a simplified synthetic model inspired by the case of WHI and
HRT.
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2.1 A Simple Model Inspired by WHI to Illustrate Confounding in
Policy Learning
We consider a simple synthetic model to illustrate the problem of confounded policy learning,
inspired by the confounding and treatment effect interactions at play in the case of the WHI
observational study on HRT. We will also use this opportunity to introduce our notation and
framework, which we will again summarize in Sec. 3.
Suppose that, for each individual, we have baseline data consisting of X 2 X , an observed
variable in the space X (usually Rd) upon which we want to personalize treatment. Specifically,
we want to assess and/or learn a policy ⇡ : X ! [0, 1] that, given an individual with covariates
X, would treat the individual with probability ⇡(X). Let us identify treatment with +1
and no treatment (control) with  1. Then treatment by policy ⇡ is a random variable
Z⇡ 2 { 1,+1} such that P (Z⇡ = 1 | X) = ⇡(X).
Usually, X would contain a rich set of features that can help drive precise and effective
treatment, as in the case of the real clinical dataset we consider in Sec. 7.2. In the example
here, for simplicity, we will consider just a univariate uniform variable, X ⇠ Unif[ 1, 1], that
represents age (normalized to lie in X = [ 1, 1]) at consideration for treatment with HRT.
As discussed in the previous section, age is considered a key factor affecting both the benefits
and the risks of HRT and should therefore potentially drive the decision of whether or not to
treat.
Each individual, at the time of consideration for treatment, is associated with a baseline
variable X as well as the potential outcomes, Y (1), Y ( 1) 2 R, indexed by each possible
treatment value, that denote the total risk plus negative benefits the individual would
experience if she were to be treated with HRT and if she were not to be treated, respectively.
In particular, Y (1) also includes any added risk, toxicity, and/or costs of intervention. The
difference in potential outcomes Y (1)  Y ( 1) is positive whenever an individual would be
harmed by HRT and negative whenever benefited. For example, Y (1)   Y ( 1) would be
very positive if HRT led to heart disease that would not have otherwise occurred and it
would be somewhat negative if HRT helped reduce menopausal symptoms without causing
additional adverse events. The potential outcomes represent only what would happen if we
were to treat or not treat. Obviously, both potential outcomes Y (1), Y ( 1) can never be
simultaneously observed for any one individual, a fundamental limitation often referred to as
the fundamental problem of causal inference (Holland 1986).
For the purpose of illustration, we construct a hypothetical model specifying the relation-
ships between these variables. We suppose that, for t 2 { 1,+1},
Y (t) = tX + 1.8(1 + t sign(X))✏ (1)
where sign(x) = 1  2I [x  0] and ✏ 2 { 1,+1} is a random disturbance independent of X
with P (✏ = +1) = ✓ where ✓ is a parameter. The difference Y (1) Y ( 1) = 2X+3.6 sign(X)✏
has two terms. The first term, 2X, corresponds to baseline heterogeneous biological effects,
where HRT is protective for younger women and but harmful for older women. The noise
term, 1.8(1 + t sign(X))✏, encapsulates the secondary effects observed in the WHI studies,
which may plausibly affect outcomes in either beneficial or harmful directions differently for
younger and older women.
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When assessing a hypothetical treatment assignment policy such as, e.g., ⇡(X) = I[X < 0]
(treat only young women), from an epidemiological public health perspective, we are primarily
interested in the average policy value, V (⇡) = E[Y (Z⇡)] = E[⇡(X)Y (1) + (1  ⇡(X))Y ( 1)].
The policy value is the population average outcome induced by policy ⇡. The policy value
can also be written as V (⇡) = E[⇡(X)⌧(X)] + E[Y ( 1)] where ⌧(X) = E[Y (1)  Y (0) | X].
The function ⌧(x) is known as the conditional average treatment effect (CATE). If CATE
were known, then it would be clearly optimal to treat a woman of age x whenever ⌧(x) < 0
and otherwise not to treat. Often, the goal of policy evaluation may actually be to assess the
benefits or harms of a candidate policy ⇡ relative to current procedure or the standard of
care, which we consider to be some baseline policy ⇡0. For example, for studying HRT based
on observational data before the trial, given the lack of existing clinical trial evidence or well-
studied biological mechanisms to support the broad use of HRT, the baseline policy is naturally
⇡0(X) = 0, assigning the control treatment to all. Thus, we may be interested in assessing
the policy regret incurred by candidate HRT treatment policy ⇡(X) relative to the population
outcomes induced by the standard of care, R⇡0(⇡) = V (⇡) V (⇡0) = E[(⇡(X) ⇡0(X))⌧ (X)].
This regret is positive whenever ⇡ would introduce net harm if it were to replace ⇡0, and it is
negative whenever ⇡ introduces net good. In our example, under eq. (1), we have that
⌧(x) = E[Y (1)  Y ( 1) | X = x] = 2X + 3.6(2✓   1) sign(x), (2)
suggesting that the optimal policy depends on the parameter ✓.
As mentioned above, in actual clinical data, Y ( 1), Y (1) are never both observed simul-
taneously. Instead, for each individual in the data, we would observe a variable T 2 { 1, 1},
indicating whether the individual was treated (T = 1) or not (T =  1), as well as the
observed outcome for that individual Y 2 R such that the observed outcome corresponds to
the potential outcome of the observed treatment, Y = Y (T ).2 The data is assumed to consist
of independent and identically distributed (IID) draws, Xi, Ti, Yi, of X, T, Y for i = 1, . . . , n.
Thus, the observed-data generating process is characterized by the joint distribution of
X, T, Y , and this distribution is the most we could hope to learn from any amount of data.
If, for different settings of (potentially infinite) parameters, a quantity that depends on the
joint distribution of X, T, Y (1), Y ( 1) (such as CATE) can take two different values while
the the joint distribution of X, T, Y remains the same, then we say that this quantity is not
identifiable. Alternatively, we say that those two values are observationally equivalent since
they cannot be distinguished from one another based on the observations we make, as the
data we see will still have the same distribution.
We now consider the specific confounding structure of the WHI observational study. In
an observational study, T may be correlated with the potential outcomes so that those that
self-selected to participate in treatment may have higher or lower overall outcomes. Similarly
plausible scenarios of unobserved confounding could have been present in the WHI study:
confounding by healthy lifestyle factors, which improves outcomes regardless of treatment, or
confounding by severity, which attenuates the perceived alleviation in vasomotor symptoms.
2The equation Y = Y (T ) captures two important features. One is that the observed outcomes are
consistent with the hypothetical potential outcomes. Another is that the outcome of an individual only
depends on the treatment assignment of that individual and there is no interference between units. This two
assumptions together are also known as the stable unit treatment value assumption (Rubin 1980).
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Figure 1: Possible values of CATE in the example in Sec. 2.1
Suppose in particular that we have that
P (T = 1 | ✏, X) = I [X  0] + sign(X)
4(1 + ✏(2✓   1)) , (3)
which is in (0, 1) for all ✓ 2 (1/8, 7/8). In our model, laid out in eqs. (1) and (3), we have
only one parameter: ✓. Let us assume that it can take any value ✓ 2 ⇥ = [1/4, 3/4]. The
parameter ✓ affects CATE, as seen in eq. (2). We next show that this parameter does not
affect the observed data and it is therefore not identifiable. Consequently neither is CATE.
Lemma 1. Suppose X, T, Y (1), Y ( 1) are as in eqs. (1) and (3). Then the joint distribution
of X, T, Y is well defined and independent of the value of ✓ for any ✓ 2 ⇥. That is, all the
values of ✓ 2 ⇥ are observationally equivalent.
This shows that, without affecting the data we would see, CATE could actually be any
function in eq. (2) for any ✓ 2 ⇥. For two examples, ✓ = 1/2 gives rise to ⌧0(x) = 2x and
✓ = 13/36 gives rise to ⌧1(x) = 2x  sign(x). Fig. 1 shows these two possible values of CATE
as well as the pointwise bounds on CATE (shaded region), that is, the minimal and maximal
values that eq. (2) can take for each value of x.
If we were to ignore the potential confounding factors, we would simply estimate CATE
using a predictive analysis of outcomes in each treatment group:
⌧˜(x) := E[Y | T = 1, X = x]  E[Y | T =  1, X = x] = 2x = ⌧0(x). (4)
If indeed there was no unobserved confounding then, once we condition on X, treatment
assignment T would be mean-independent of the potential outcomes Y (1), Y ( 1) (i.e.,
E[Y (t) | T,X] = E[Y (t) | X] for t 2 { 1, 1}). If this were the case then ⌧˜(x) would be
guaranteed to be equal to CATE. In fact, with or without unobserved confounding, Eq. (4) is
precisely what is estimated by any method that assumes unconfoundedness, including, e.g.,
Shalit et al. (2017), Wager and Athey (2017b) or a direct regression analysis on eq. (4).
We plot ⌧˜ in Fig. 1 (dashed line). Since it is equal to ⌧0, it is also a feasible function in
eq. (2). Now, suppose we were to use this observational estimate as our guess for CATE and
make our treatment decisions correspondingly. This would suggest that we should treat all
women of ages x < 0 and not treat the rest. If indeed ⌧(x) = 2x then this would lead to a
regret of  1 compared to never treat, meaning we would be doing net good by targeting
younger women for treatment. However, since CATE can actually be any function in eq. (2)
for any ✓ 2 ⇥, the true regret of this policy can be as bad as 0.8, meaning that we could be
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introducing a significant amount of net harm, possibly causing higher rates of adverse events
such as heart disease and cancer because of hasty predictive analysis of observational data
leading to overeager intervention. This highlights the potential pitfalls of unchecked policy
learning and poses a critical barrier to personalizing medical treatments based on EMRs,
where confounding is sure to be a factor.
This clearly shows that it is indeed not clear that women of ages x < 0 would necessarily
be helped by HRT: the value of CATE could be positive. But this also clearly shows that
women of ages x <  0.9 do necessarily benefit from treatment: for them, all possible CATEs
are bounded below zero. Here, this suggest a much more cautious intervention strategy,
where we treat only women of ages x <  0.9 and not treat the rest. Over all possible values
of ✓ 2 ⇥, this will have regret no worse than  0.1 relative to never treat, meaning that we
are assured some net benefit. This highlights that even if we do not know the true value of
CATE, we might still be able to identify subgroups of the population that would be ensured
benefit from intervention.
Surprisingly, we could actually do better than that by more carefully addressing the policy
learning problem rather than viewing this as just a predictive analysis (with identification
bounds). Suppose we were searching over depth-2 tree-based policies, that is, a policy that
can be written as two nested queries about the value of x being above or below a threshold
and assigning the same value ⇡(x) to all values in a leaf node. Consider such a policy which
treats women of ages x 2 [ 1, 0.5] [ [0, 0.5]. Over all possible values of ✓ 2 ⇥, this policy
will have regret no worse than  0.5 relative to never treat, which is significantly better than
the above approach. This policy in fact turns out to be minimax optimal for this problem,
that is, it minimizes the maximal regret. This is exactly the approach we will take in this
paper: search over a restricted policy class to find the policy that minimizes the maximal
value that regret can take, given what can and cannot be identified from the data. This
directly targets the policy learning problem (rather than addressing the predictive problem)
while carefully accounting for potential confounding and is able to identify a policy that,
despite potential confounding in the data, is still assured to never introduce harm and in fact
bestow a significant net benefit whenever possible.
In the following, rather than this simplistic one-parameter model, we will use a more
natural and flexible approach to characterize the potential unobserved confounding, known
as the Rosenbaum model. Before proceeding to develop our particular method, we review
some of the relevant background and the literature upon which we draw.
3 Problem Statement and Preliminaries
We first summarize the setup. We consider policy learning from observational data consisting
of tuples of random variables {(Xi, Ti, Yi) : i = 1, . . . , n}, comprising of covariates Xi 2 X ,
assigned treatment Ti 2 { 1, 1}, and real-valued outcomes Yi 2 R. We let Yi( 1), Yi(1)
denote the potential outcomes of applying treatment  1 and 1, respectively. We use the
convention that the outcomes Yi corresponds to losses so that lower outcomes are better. We
consider evaluating and learning a (potentially randomized) policy mapping covariates to the
probability of assigning treatment, ⇡ : X ! [0, 1], where we focus on a policy class ⇡ 2 F of
restricted complexity. Examples include linear policies ⇡p0,p1,↵, (x) = p0 + (p1  p0)I[↵+  |x],
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logistic policies ⇡↵, (x) =  (↵+ |x) where  (z) = 1/(1+e z), or decision trees of a bounded
depth, which assign any probability to each leaf of the tree. Define policy value of ⇡ as
V (⇡) = E[⇡(Xi)Y (1) + (1  ⇡(Xi))Y ( 1)].
Without loss of generality, we assume that there is an additional (but unobserved)
covariate Ui such that unconfoundedness would hold if we were to control for both Xi
and Ui, that is, such that E[Yi(t) | Xi, Ui, Ti] = E[Yi(t) | Xi, Ui] for t 2 { 1, 1}, and
we define e(Xi, Ui) = P (T = 1 | Xi, Ui). This is without loss of generality as it holds for
Ui = P (T = 1 | X, Yi( 1), Yi(1)). Equivalently, we can treat the data as collected under an
unknown logging policy that based its assignment on both Xi and Ui and that assigned
Ti = 1 with probability e(Xi, Ui). Here, e(Xi, Ui) is precisely the true propensity score
of unit i. Since we do not have access to Ui in our data, these too are unobserved, and
instead we only have access to nominal propensities eˆ(Xi) = P (T = 1 | Xi). These do not
account for the potential unobserved confounding. We assume that these are part of the
data. Indeed, they can be estimated directly from the data using a probabilistic classification
model such as logistic regression or a neural network. For compactness, we denote eˆTi(Xi) =
1
2
(1+Ti)eˆ(Xi)+
1
2
(1 Ti)(1 eˆ(Xi)) and eTi(Xi, Ui) = 12(1+Ti)e(Xi, Ui)+ 12(1 Ti)(1 e(Xi, Ui)).
3.1 Related Work
Our work builds upon several strands of literatures, notably policy learning from observational
data as well as sensitivity analysis in causal inference.
Causal inference for personalization from observational data under uncon-
foundedness. The key difficulty in learning interventional effects from observational
data is that the outcome Yi(Ti) is only observed for the treatment actually administered
historically to the unit, Ti, whose assignment can itself be correlated with the potential
outcomes, obfuscating differences in them. Since the data is observational and the treatment
assignment procedure was not under the control of the experimenter, the distribution of
covariates may be systematically different between treatment and control groups due to
self selection of the individuals into treatments, medical imperatives trading off treatment
risk vs. patient severity, or business imperatives to offer discounts or target advertising
not completely at random. Thus, the systematic differences in covariates in the population
P (X = x, U = u | T = 1) ,P (X = x, U = u | T =  1), also known as covariate shift, make
the treated and untreated populations incomparable for the purpose of assessing effect.
When all covariates needed to ensure unconfoundedness are assumed to be observed,
i.e, U is null and unconfoundedness holds with respect to the observed X (i.e., E[Y (t) |
X, T ] = E[Y (t) | X] for t 2 { 1, 1}), then a variety of approaches for learning personalized
intervention policies that maximize causal effect have been proposed. These fall under
regression-based strategies (Bertsimas et al. 2016, Qian and Murphy 2011), reweighting-
based strategies (Beygelzimer and Langford 2009, Kallus 2017a, Kitagawa and Tetenov
2018, Swaminathan and Joachims 2015b), or doubly robust combinations thereof (Dudik
et al. 2014, Wager and Athey 2017a). Regression-based strategies estimate the conditional
average treatment effect (CATE), E[Y (1)   Y ( 1) | X], either directly or by differencing
two regressions estimated separately on the treated and untreated populations since, under
unconfoundedness, E[Y | T = 1, X]   E[Y | T =  1, X] = E[Y (1) | X]   E[Y ( 1) | X].
These estimates are either used directly to treat by comparing it to zero (known as direct
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comparison) or to score policies and pick the best in a restricted class (know as the direct
method). If the CATE function is ill-specified, we are not guaranteed to find the best policy,
even if the class is amenable to the estimation method (e.g., the best linear policy does not
arise from comparing the best linear CATE estimator to zero). Of course, as we have seen in
Sec. 2.1, without unconfoundedness, CATE is not identifiable from the data (parametrically
or non-parametrically) and these methods have no guarantees.
Reweighting-based strategies use inverse propensity weighting (IPW) (Beygelzimer and
Langford 2009, Kallus 2017a, Kitagawa and Tetenov 2018, Swaminathan and Joachims
2015b) or covariate-balancing weights (Kallus 2017b) to change measure from the distribution
induced by a historical logging policy to that induced by any new policy ⇡. Specifically, these
methods use the fact (Li et al. 2011) that, under unconfoundedness, Vˆ IPW(⇡) is unbiased for
V (⇡), where
Vˆ IPW(⇡) =
1
n
nX
i=1
(1 + Ti(2⇡(Xi)  1))Yi
2eˆTi(Xi)
(5)
This estimator is often centered with respect to Vˆ IPW(⇡0) for ⇡0(x) = 1/2 since then, for
deterministic policies, each term is either plus or minus of Yi/eˆTi(Xi), depending on whether
Ti = 2⇡(Xi)  1. Optimizing Vˆ IPW(⇡) for deterministic policies can be phrased as a weighted
classification problem (Beygelzimer and Langford 2009). Dudik et al. (2014) suggest to
augment eq. (5) by using the doubly-robust estimator (Robins et al. 1994), which centers the
outcomes using a regression estimate. Wager and Athey (2017a) show that since this estimate
is semiparametrically efficient when using cross-fold fitting, as shown by Chernozhukov et al.
(2016), this leads to better regret bounds. Since dividing by propensities can lead to extreme
weights and high variance estimates, clipping the probabilities are typically necessary for
good performance (Swaminathan and Joachims 2015a, Wang et al. 2017) or the use of weights
that directly optimize for balance (Kallus 2017b). With or without any of those fixes, if there
are unobserved confounders, then, as we have seen in Sec. 2.1, neither a policy’s value not
the optimal policy are identifiable, and any of these methods may lead to learned policies
that introduce more harm than good.
Under unconfoundedness, such reweighting-based methods are notable for being able to
find best-in-class policies regardless of specification of an outcome model (or with outcome
models learned at sub-parametric rates; Wager and Athey 2017a). Specifically, they focus
directly on the policy learning problem rather than a prediction problem and on finding
a policy that performs as the best in a given class. This leads to strong generalization
guarantees (Kallus 2017b, Kitagawa and Tetenov 2018, Wager and Athey 2017a) and can also
allow one to incorporate domain-specific constraints that favor simple prescriptive decision
policies that are interpretable, implementable, and/or satisfy operational constraints, such as
scorecards or decision-trees (Ustun and Rudin 2015). These constraints and approaches for
training optimal constrained policies can be composed directly with the policy optimization
problem by restricting the policy class. Because of these unique properties, our approach
will also be based on a reweighting approach that directly optimizes a policy rather than a
predictor. Our approach additionally, and crucially, handles the commonplace yet detrimental
issue of unobserved confounding.
Policy improvement. A separate literature within reinforcement learning, unrelated
to causal inference, considers the idea of safe policy improvement by forming an uncertainty
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set around the presumed unknown transition probabilities between states as in Thomas et al.
(2015) or forming a trust region for safe policy exploration via concentration inequalities
on estimates of policy risk as in Petrik et al. (2016). None of these consider the issue of
confounding or observational data. This general approach of safely improving upon another
policy using a robust or minimax formulation is related to, and inspires the name of, our
method.
Sensitivity analysis. Sensitivity analysis in causal inference tests the robustness of
qualitative conclusions (usually, that there is or is not an effect) made based on observa-
tional data to model specification and/or to assumptions, such as unconfoundedness. Some
approaches for assessing unconfoundedness require auxiliary data or additional structural
assumptions, which we do not assume here (Imbens and Rubin 2015). Other approaches
consider how large confounding must be to invalidate the conclusions using the Rosenbaum
model (Rosenbaum 2002). Our approach uses the Rosenbaum model and focuses on the
implications for personalized treatment decisions.
The Rosenbaum model for sensitivity analysis assesses the robustness of randomization
inference to the presence of unobserved confounding by considering a uniform bound on
the odds ratio between true and nominal propensities, motivated by a logistic specification
(Rosenbaum 2002). Such a restriction corresponds to a model where the odds-ratio for
treatment between two units with the same covariates Xi = Xj , which differs due to the units’
different values Ui, Uj for the unobserved confounder, is  Ui Uj , where   is a parameter and
Ui, Uj 2 [0, 1] may be arbitrary. The value of   can be calibrated against the discrepancies
induced by omitting observed variables; then determining   can be phrased in terms of
whether one thinks one has omitted a variable that could have increased or decreased the
probability of treatment by as much as, say, gender or age can in the observed data (Hsu
and Small 2013). The general approach taken by sensitivity analyses in this model is to
use randomization inference to assess how big the p-value on the hypothesis of no effect can
be depending on the value of   so that such binary conclusions can be couched in terms of
the level of unobserved confounding (Fogarty and Small 2016, Hasegawa and Small 2017,
Rosenbaum 2002).
In the sampling literature, the Hájek estimator for population mean (Hájek 1971) is an
extension of the classic Horvitz-Thompson estimator (Horvitz and Thompson 1952) that adds
weight normalization. The objective of the minimax game we define between policy optimizer
and possible confounding is a Hájek estimator for the policy value. Aronow and Lee (2012)
derive sharp bounds on the estimator arising from a uniform bound on the sampling weights,
showing a closed-form for the solution for a uniform bound on the sampling probabilities.
Zhao et al. (2017) consider bounds on the Hájek estimator, but impose a parametric model
on the treatment assignment probability. Miratrix et al. (2018) consider tightening the
bounds from the Hájek estimator by adding shape constraints, such as log-concavity, on the
cumulative distribution of outcomes.
4 Robust policy evaluation and improvement
We now present our framework for confounding-robust policy improvement. Our approach
minimizes a bound on policy regret against a specified baseline policy ⇡0, R⇡0(⇡) = V (⇡) 
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V (⇡0). Our bound is achieved by maximizing a reweighting-based regret estimate over an
uncertainty set around the nominal propensities. This ensures that we cannot do any worse
than ⇡0 and may in fact do better, even if the data is confounded.
The baseline policy ⇡0 can be any fixed policy that we want to make sure not to do worse
than or deviate from unnecessarily. This is usually the current standard of care, established
from prior evidence, and we would not want any algorithmic solution to personalization to
introduce any harm relative to current standards. Generally, this is the policy that always
assigns control, ⇡0(x) = 0. Alternatively, if reliable clinical guidelines exist for some limited
personalization, then p0(x) represent the non-constant function that encodes these. In an
intervention-agnostic extreme, ⇡0 can also be the complete randomization policy, ⇡0(x) = 1/2.
4.1 Confounding-robust policy learning by optimizing minimax re-
gret
If we had oracle access to the true inverse propensities W ⇤i = 1/eTi(Xi, Ui) we could form the
correct IPW estimate by replacing nominal with true propensities in eq. (5). We may go a
step further and, recognizing that E[W ⇤i ] = 2, use the empirical sum of true propensities as a
control variate by normalizing our IPW estimate by them. This gives rise to the following
Hájek estimators of V (⇡) and correspondingly R⇡0(⇡):
Vˆ ⇤(⇡) =
Pn
i=1W
⇤
i (1 + Ti(2⇡(Xi)  1))YiPn
i=1W
⇤
i
,
Rˆ⇤⇡0(⇡) = Vˆ
⇤(⇡)  Vˆ ⇤(⇡0) = 2
Pn
i=1W
⇤
i (⇡(Xi)  ⇡0(Xi))TiYiPn
i=1W
⇤
i
It follows by Slutsky’s theorem that these estimates remain consistent (if we know W ⇤i ). Note
that had we known W ⇤i , both the normalization and choice of ⇡0 would have amounted to
constant shifts and scales to Rˆ⇤⇡0(⇡) that would not have changed which policy ⇡ minimizes
the regret estimate and is therefore learned. This will not be true of our bound, where both
the normalization and the choice of ⇡0 will be material to the success of the method.
Since the oracle weights W ⇤i are unknown, we instead minimize the worst-case possible
value of our regret estimate, by ranging over the space of possible values for eTi(Xi, Ui) that are
consistent with the observed data and our assumptions about the confounded data-generating
process. Specifically, our model restricts the extent to which unobserved confounding may
affect assignment probabilities. We first consider an uncertainty set motivated by the odds-
ratio characterization in Rosenbaum (2002), which restricts how far the weights can vary
pointwise from the nominal propensities. Given a bound   > 1, the odds-ratio restriction on
e(x, u) is that it satisfy the following inequalities
  1  (1  eˆ(x))e(x, u)
eˆ(x)(1  e(x, u))   . (6)
This restriction is motivated by (but more general than) considering an additive model where
e(x, u) =  (g(x) + h(u)), g is any function and |h(u)|  log( ). The choice of   can be
calibrated using, e.g., the method of Hsu and Small (2013).
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Note that, by symmetry, eq. (6) can equivalently be written in terms of the functions
eˆT (x), eT (x, u). Therefore, we see that the restriction in eq. (6) immediately leads to the fol-
lowing uncertainty set for the true inverse propensity weights of each unit,W ⇤i = 1/eTi(Xi, Ui),
centered around the nominal inverse propensity weights, Wˆi = 1/eˆTi(Xi), that do not account
for all confounding:
W ⇤i 2 U n =
 
W 2 Rn+ : a i  Wi  b i 8i = 1, . . . , n
 
, where (7)
a i = 1 +  
 1(Wˆi   1), b i = 1 +  (Wˆi   1)
The corresponding bound on the empirical regret Hájek estimator is R⇡0(⇡;U n ), where for
any U ⇢ Rn+ we define
R⇡0(⇡;U) = sup
W2U
2
Pn
i=1Wi(⇡(Xi)  ⇡0(Xi))TiYiPn
i=1Wi
. (8)
Note that R⇡0(⇡;U) = R⇡0(⇡;
S
t>0(tU)) for any U ⇢ Rn+ so that any uncertainty set can be
made to also include all its scalings without inflating the objective, eq. (8).
We then choose the policy ⇡ in our class F to minimize this regret bound, i.e., ⇡(F ,U n , ⇡0),
where
⇡(F ,U , ⇡0) 2 argmin
⇡2F
R⇡0(⇡;U) (9)
In particular, for our worst-case regret objective R⇡0(⇡;U n ), weight normalization is crucial
for only enforcing robustness against consequential realizations of confounding that affect
the relative weighting of patient outcomes. Any mode of the confounding that affects all
weights similarly should have no effect on policy choice. Moreover, even if we do not know
Ui or W ⇤i , we know that they must satisfy E[W ⇤i ] = 2, so any realization that violates that
is impossible. Moreover, different baseline policies ⇡0 structurally change the solution to
the adversarial subproblem by shifting the contribution of the loss term YiTi(⇡(Xi)  ⇡0) to
emphasize improvement upon different baselines. In particular, if the baseline policy is in the
policy class F , it already achieves 0 regret; thus, minimizing regret necessitates learning a
policy that must offer some benefits in terms of decreased loss regardless of confounding.
4.2 Budgeted uncertainty sets to address “local” confounding
The above uncertainty set, eq. (7), might be pessimistic in ensuring robustness against every
possible worst-case realization of unobserved confounding for each unit, whereas concerns
about unobserved confounding might be limited to subgroup risk factors or outliers. For
the Rosenbaum model in hypothesis testing, this has also been recognized by Fogarty and
Hasegawa (2017), Hasegawa and Small (2017) in the context of classic sensitivity analysis.
Motivated by this, we next consider an alternative uncertainty set, where we fix a budget of
uncertainty ⇤ for how much the weights can diverge from the nominal inverse propensity
weights in total. Specifically, we construct the uncertainty set
U ,⇤n =
(
W 2 Rn+ :
nX
i=1
|Wi   Wˆi|  ⇤, a i  Wi  b i 8i = 1, . . . , n
)
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When plugged into eq. (9), this provides an alternative policy choice criterion that is less
conservative. To make the choice of parameters easier, we suggest to calibrate ⇤ as a fraction,
⇢ < 1, of the total deviation already allowed by U n . Specifically, ⇤ = ⇢
Pn
i=1 max(Wˆi  
a i , b
 
i   Wˆi). This is the approach we take in our empirical investigation.
5 The Improvement Guarantee
Before discussing how we actually algorithmically compute ⇡ in eq. (9), we next prove a
statistical guarantee about it that shows that, if we appropriately bounded the potential
hidden confounding, then the optimal value of our worst-case empirical regret objective, that
is, that achieved by ⇡, is asymptotically an upper bound on the true population regret of
⇡. The result is in fact a finite-sample result that gives precisely a bound on how much the
latter might exceed the former due to finite-sample errors – terms that vanish as n grows,
even if there is unobserved confounding. On the one hand, since our objective is necessarily
non-positive if ⇡0 2 F , this says we will never do worse (up to vanishing terms). On the
other hand, if our objective is sufficiently negative, which we can check by just evaluating it,
then we are assured some strict improvement. Our result is generic for both the uncertainty
sets we defined above, U n and U ,⇤n .
Our upper bound depends on the flexibility of our policy class. It is critical that we search
over a flexible but not completely unrestricted class in order to get an improvement. We
express the flexibility of F using the notion of Vapnik-Chervonenkis (VC) dimension (Vapnik
1998), which we define below.3
Definition 1. The VC dimension of F is the largest number v 2 N such that there exists
x1, . . . , xv 2 X with
{(I [⇡(x1)  ✓] , . . . , I [⇡(xv)  ✓]) : ⇡ 2 F , ✓ 2 R} = {0, 1}v. (10)
If eq. (10) holds then we say F shatters x1, . . . , xv, which means that any subset of the
points belong exclusively to some sublevel set of some ⇡ 2 F and its complement to the
corresponding superlevel set. The more complex a class is, the larger the point sets it can
shatter. Thus, VC dimension is a natural expression of function class complexity or flexibility.
If X = Rd, then the VC dimension of both the linear policies and logistic policies is d+ 1.
For binary decision trees of depth no more than D, if each inner node can be a query xi  ✓
for any i = 1, . . . , d and ✓ = ✓i1, . . . , ✓iK and each leaf node is assigned its own probability,
then the VC dimension of this class is at most 2D log2(dK + 2). In general, all policy classes
we consider have a bounded VC dimension.
Our bound also requires that outcomes have nice tails; specifically, subgaussian tails.
Definition 2. A random variable Z with EZ = 0 is said to be subgaussian with parameter
 2 if for all   2 R we have
E exp( Z)  exp( 2 2/2).
3This follows the definition of VC major classes of subgraphs as introduced by Dudley (1987).
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In particular, a normal random variable N (0,  2) is subgaussian with parameter  2 and a
zero-mean random variable bounded in [ B,B] is subgaussian with parameter B2.
Our guarantee is then as follows:
Theorem 1. Suppose that (1/eT1(X1, U1), . . . , 1/eTn(Xn, Un)) 2
S
t 0(t U), that ⌫  e(x, u) 
1   ⌫ for some ⌫ > 0, that Y   µ is subgaussian with parameter  2 where µ = EY , and
that the VC dimension of ⇧ is no more than v 2 N. Then for any   > 0 such that
n   max
⇣
log(39/ )
2⌫2
, 8
µ2/ 2+8
⌘
, we have that with probability at least 1   ,
R⇡0(⇡) = V (⇡)  V (⇡0)  R⇡0(⇡;U) +
73
p
v
p
µ2 + 8 2 log(39/ )
⌫2
p
n
8⇡ 2 F (11)
In particular, if we let ⇡ = ⇡(F ,U , ⇡0) be as in eq. (9) then eq. (11) holds for ⇡ since it
holds uniformly. This is nice because ⇡ minimizes the right hand side, which bounds its true
regret. Moreover, the second term on the right hand side of eq. (11) vanishes as n!1 at a
rate of O(n 1/2), regardless of any unobserved confounding. So, if the objective R⇡0(⇡;U)
is negative, we are (almost) assured of getting some improvement on ⇡0 (up to O(n 1/2)
errors). At the same time, so long as ⇡0 2 ⇧, the objective is necessarily non-positive,
R⇡0(⇡;U)  0, so we are also (almost) assured of doing no worse than ⇡0 (up to O(n 1/2)
errors). All this, without ever being able to identify or estimate any population effect or any
one individual-level effect, due to the unobserved confounding. Thus, Theorem 1 exactly
captures the special appeal of our approach.
6 Algorithms for Optimizing Robust Policies
We next discuss how to algorithmically solve the policy optimization problem in eq. (9) and
actually find the confounding-robust policy, ⇡. The solution method will depend on the
policy class we consider optimizing over; we consider two cases. One case is differentiable
parametrized policy classes, F = {⇡( · ; ✓) : ✓ 2 ⇥} such that ⇡(x; ✓) is differentiable with
respect to ✓, such as logistic policies. In this case we will use subgradient descent to find the
robust policy. The other case is decision-tree based policies, where we will use mixed-integer
optimization. In both cases, our solution will depend on a characterization of the inner
worst-case regret subproblem.
We next discuss how to solve the worst-case regret subproblem for a fixed policy, which
we will then use to develop our algorithms.
6.1 Dual Formulation of Worst-Case Regret
The minimization in eq. (9) involves an inner supremum, namely R⇡0(⇡;U n ). Moreover,
this supremum over weights W does not on the face of it appear to be a convex problem.
However, a standard transformation will reveal its convexity. We next proceed to characterize
this supremum, formulate it as a linear program, and, by dualizing it, provide an efficient
line-search procedure for finding the pessimal weights.
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For compactness and generality, we address the optimization problem Q(r;U n ) parame-
terized by an arbitrary reward vector r 2 Rn, where
Q(r;U) = max
W2U
Pn
i=1 riWiPn
i=1Wi
. (12)
To recover R⇡0(⇡;U), we would simply set ri = 2(⇡(Xi)  ⇡0(Xi))TiYi.
First we consider U n . Since U n involves only linear constraints on W , eq. (12) for U = U n
is a linear fractional program. We can reformulate it as a linear program by applying the
Charnes-Cooper transformation (Charnes and Cooper 1962), requiring weights to sum to 1,
and rescaling the pointwise bounds by a nonnegative scale factor t. We obtain the following
equivalent linear program in normalized weight variables w:
Q(r;U n ) = maxt 0,w 0
nX
i=1
riwi
s.t.
nX
i=1
wi = 1
ta   w  tb  8 i = 1, . . . , n
(13)
The dual problem to eq. (13) has dual variables   2 R for the weight normalization constraint
and u, v 2 Rn+ for the lower bound and upper bound constraints on weights, respectively. By
linear programming duality, we then have that
Q(r;U n ) = minu 0,v 0,   
s.t.   v|b  + u|a    0
vi   ui +     ri 8 i = 1, . . . , n
(14)
We use this to show that solving the inner subproblem requires only sorting the data and
a ternary search to optimize a unimodal function. This generalizes the result of Aronow
and Lee (2012) for arbitrary pointwise bounds on the weights. Crucially, the algorithmically
efficient solution will allow for faster subproblem solutions when optimizing our regret bound
over policies in a given policy classes.
Theorem 2 (Normalized optimization solution). Let (i) denote the ordering such that r(1) 
r(2)  · · ·  r(n). Then, Q(r;U n ) =  (k⇤), where k⇤ = inf{k = 1, . . . , n+1 :  (k) <  (k   1)}
and
 (k) =
P
i<ka
 
(i)r(i) +
P
i kb
 
(i)r(i)P
i<ka
 
(i) +
P
i kb
 
(i)
(15)
Moreover,  (k) is a discrete concave unimodal function.
Next we consider Q(r;U ,⇤n ). Write an extended formulation for U ,⇤n using only linear
constraints:
U ,⇤n =
(
W 2 Rn+ : 9d s.t.
nX
i=1
di  ⇤, di   Wi   Wˆi, di   Wˆi  Wi, a i  Wi  b i 8i
)
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This immediately shows that Q(r;U ,⇤n ) remains a fractional linear program. Indeed, a similar
Charnes-Cooper transformation as used above yields a non-fractional linear programming
formulation:
Q(r;U ,⇤n ) = maxt 0,w 0,d
nX
i=1
wiri
s.t.
nX
i=1
di  ⇤t,
nX
i=1
wi = 1
a i t  wi  b i t 8 i = 1, . . . , n
di   wi   Wˆit 8 i = 1, . . . , n
di   Wˆit  wi 8 i = 1, . . . , n
The corresponding dual problem is:
Q(r;U ,⇤n ) = ming 0,h 0,u 0,v 0,⌫ 0,   
s.t. vi   ui + gi   hi +     ri 8 i = 1, . . . , n
vi   gi + hi 8 i = 1, . . . , n
  b|v + a|u  ⇤⌫ + g|Wˆ + h|Wˆ   0
As Q(r;U ,⇤n ) remains a linear program, we can easily solve it using off-the-shelf solvers, even
if it does not admit as simple of a solution as Q(r;U n ) does.
6.2 Optimizing Parametric Policies
We next consider the case where F = {⇡(·; ✓) : ✓ 2 ⇥}, ⇥ is convex (usually ⇥ = Rm), and
⇡(x; ✓) is differentiable with respect to ✓. We suppose that r✓⇡(x; ✓) is given as an evaluation
oracle. An example is logistic policies where ⇡(X;↵,  ) =  (↵ +  |X) and ⇥ = Rd+1. Since
 0(z) =  (z)(1   (z)), evaluating derivatives is simple.
Our method follows a parametric optimization approach (Still 2018). Note that Q(r;U) is
convex in r since it is a maximum over linear functions in r. Correspondingly, its subdifferential
at r is given by the argmax set:
@rQ(r;U) =
⇢
WPn
i=1Wi
: W 2 U ,
Pn
i=1WiriPn
i=1Wi
  Q(r;U).
 
If we set ri(✓) = 2(⇡(Xi; ✓)   ⇡0(Xi))TiYi, so that Q(r;U) = R⇡0(⇡(·; ✓);U), then @ri(✓)@✓j =
2TiYi
@⇡(Xi;✓)
@✓j
. Although F (✓) := R⇡0(⇡(·; ✓);U) may not be convex in ✓, this suggests a
subgradient descent approach. Let
g(✓;W ) = r✓ 2
Pn
i=1Wi(⇡(Xi; ✓)  ⇡0(Xi))TiYiPn
i=1Wi
=
2
Pn
i=1WiTiYir✓⇡(Xi; ✓)Pn
i=1Wi
.
Note that whenever @rQ(r(✓);U) = {W/
Pn
i=1Wi} is a singleton then g(✓;W ) is in fact a
gradient of F (✓).
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Algorithm 1 Parametric Subgradient Descent
1: Input: step size ⌘0, step-schedule exponent  2 (0, 1], initial iterate ✓0, number of
iterations N
2: for t = 0, . . . , N   1 do:
3: ⌘t  ⌘0t  . Update step size
4: `t,W  max
W2U
, 2 argmax
W2U
2
Pn
i=1Wi(⇡(Xi;✓t) ⇡0(Xi))TiYiPn
i=1Wi
. Solve inner subproblem for ✓t
5: ✓t+1  Projection⇥(✓t   ⌘tg(✓t;W )) . Move in subgradient direction
6: return ✓argmint lt
At each step, our algorithm starts with a current value of ✓, then proceeds by finding the
weights W that realize R⇡0(⇡(· ; ✓) by using an efficient method as in the previous section,
and then takes a step in the direction of  g(✓;W ). Using this method, we can optimize
policies over both the unbudgeted uncertainty set U n and the budgeted uncertainty set U ,⇤n .
Because descent is not always guaranteed at each step, at the end, we return the value of ✓
that corresponds to the best objective value seen so far. Our method is summarized in Alg. 1.
6.3 Optimal Confounding-Robust Trees
We next consider the function class consisting of axis-aligned decision tree policies where each
leaf is assigned a constant probability of treatment. Decision tree policies are advantageous
due to their simplicity and interpretability. Our optimal confounding-robust tree (OCRT)
presented below determines the best confounding-robust decision tree via global optimization
using mixed-integer optimization. Our approach is to combine the dual linear program
formulation of R⇡0(⇡;U n ) in eq. (14) with a mixed-integer formulation of this class of decision
trees, following the formulation of Bertsimas and Dunn (2017), along with a special heuristic
to find a good warm start.
A decision tree (with maximal splits) of a fixed depth D can be represented by an array
labeled by a set of nodes, split into a set of branching nodes TB and leaf nodes TL. The space
of decision tree policies is parametrized by ⇥ = {{at, bt}t2TB , {ct}t2TL}, where at, bt 2 Rp
parametrize the split at branching node t, which directs units to the left branch if a|x < b,
and to the right branch otherwise. The policy assignment probability is parametrized by
ct 2 [0, 1] for t 2 TL. We consider axis-aligned splits such that at is a unit vector.
We let the binary assignment variables zit track assignment of data points i to leaves
t 2 TL subject to the requirement that every instance is assigned to a leaf node according to
the results of axis-aligned splits a|tx < bt, for splits occurring at t 2 TB branch nodes. The
binary variables dt track whether a split occurs at node t 2 TB. The binary variable lt tracks
whether a leaf is empty or not. The policy optimization determines both the partitions of
the covariates governing assignment to terminal leaf nodes and the variables ct for t 2 TL
governing probability of treatment assignment in the leaf nodes. We denote par(t) as the
parent of node t, A(t) as the set of all ancestors of node t, and the subsets AL(t)[AR(t) = A(t)
denote the sets of ancestor nodes where the instance was split to the left or right, respectively.
In this section, we assume that the covariates are rescaled such that each covariate lies in
[0, 1].
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We introduce additional constraints to encode our dual objective in the optimal classifi-
cation tree framework. We define the policy assignment probability P i =
P
t2⌧L zitct where
ct is the policy assignment probability of leaf node t 2 ⌧L, and zit describes whether or not
instance i is assigned to leaf node t, enforced with the additional set of auxiliary big-M
constraints for the product of a binary variable and continuous variable (for the case of two
treatments).
pi,t  zit; pi,t  ct; pi,t   ct + zit   1 8i = 1, . . . , n, t 2 TL
P i =
X
t2⌧L
pi,t 8i = 1, . . . , n
pi,t 2 [0, 1] 8i = 1, . . . , n, t 2 TL
ct 2 [0, 1] 8t 2 TL
Pi 2 [0, 1] 8i = 1, . . . , n
The combined formulation for policy optimization with confounding-robust optimal trees
is as follows:
min   (16a)
s.t. vi   ui +     Yi(Pi   ⇡0)Ti 8i = 1, . . . , n (16b)
  (b )|v + (a )|u   0 (16c)
pi,t  zit, pi,t  ct, pi,t   ct + zit   1 (16d)
P i =
P
t2⌧Lp
i,t (16e)
a|m(xi + ✏)  bm + (1  zit) 8i = 1, . . . , n, 8t 2 TB, 8m 2 AL(t) (16f)
a|m(xi + ✏)  bm   (1 + ✏max)(1  zit) 8i = 1, . . . , n, 8t 2 TB, 8m 2 AR(t) (16g)P
t2TLzit = 1 8t 2 TB (16h)Pn
i=1 zit   Nminlt 8i = 1, . . . , n (16i)Pp
j=1ajt = dt (16j)
0  bt  dt 8t 2 TB (16k)
dt  dpar(t) 8t 2 TB \ {1} (16l)
lU(t)   d(par(t)) t 2 TB \ 1 (16m)
lt  dpar(m) 8m 2 TB, t 2 [D(tb), U(tb)] (16n)
lt   dpar(t) 8t 2 TL (16o)
zit, lt 2 {0, 1} i = 1, . . . , n, 8t 2 TL (16p)
ajt, dt 2 {0, 1} j = 1, . . . , p, 8t 2 TB (16q)
pi,t 2 [0, 1] i = 1, . . . , n, 8t 2 TL (16r)
ct 2 [0, 1] 8t 2 TL (16s)
u, v   0 (16t)
Constraints (16d, 16e) set the policy assignment variable Pi 2 [0, 1], which is the sum of
products pi,t = zitct over leaf nodes. Our objective is specified via the dual formulation,
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Figure 2: Out of sample policy regret on simulated data in Sec. 7.1
and constraints (16b, 16c) encode the constraints from the dual of the inner maximization
subproblem. Constraints (16f, 16g) enforce that if a node is in a leaf (as indicated by zit), it
satisfies the splits at ancestor nodes. Constraint (16h) enforces that each instance is in a leaf
node, while constraint 16i enforces a size constraint on leaf membership. Constraints (16j,
16l, 16k) enforce consistency constraints between d, indicating whether a split occurs at leaf
node t, and split variables ajt, bt. {D(t)}t2TB denotes the set of leaf nodes of smallest index
which can be reached from splits at t, and similarly {U(t)}t2TB denotes the set of reachable
leaf nodes of largest index. Constraints (16m, 16n, 16o) enforce that leaves are non-empty
only if splits do occur in the relevant ancestor nodes.
For the mixed-integer linear program, we provide a warm start for the optimization via a
recursive partitioning-based approach which incrementally optimizes directly the robust risk,
over iterative refinements of either the constant all-treat or all-control policy, described in
Sec. B of the appendix.
7 Empirical Results
In this section we present empirical results on two experiments to investigate the benefit of
confounding robustness. Our first experiment is a simple synthetic example that we use to
illustrate the different methods in a controlled setting. Our second experiment investigates
a large-scale clinical dataset on the treatment of acute ischaemic stroke. There, the harm
done by unwarranted aggressive intervention by personalized policy learning led astray by
confounding is serious, causing more deaths and other adverse effects than conservative
standards of care. Our more careful approach to learning to personalized policies is able to
avoid such harm but still offer sizable improvements over baseline by personalizing care.
7.1 Simulated data
We first consider a simple linear model specification demonstrating the possible effects of
significant confounding on inverse-propensity weighted estimators. We generate our data as
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follows:
⇠ ⇠ Bern(1/2), X ⇠ N(µx(2⇠   1), I5), U = I[Yi(1) < Yi( 1)]
Y (t) =  |0x+ 1/2(t+ 1) 
|
treatx+ ↵1/2(t+ 1) + ⌘⇠t+ !⇠ + ✏
The constant treatment effect is 2.5 with the linear interaction  treat = [ 1.5, 1, 1.5, 1, 0.5].
The covariate mean is µx = [ 1, .5, 1, 0, 1]. The noise term ⇠ affects outcomes with
coefficients ⌘ =  2,! = 1, in addition to a uniform noise term ✏ ⇠ N(0, 1). We let the
nominal propensities be logistic in X, eˆ(Xi) =  ( |x) with   = [0, .75, .5, 0, 1, 0], and we
generate Ti according to the true propensities, which we set to
e(Xi, Ui) =
4 + 5U + eˆ(Xi)(2  5U)
6eˆ(Xi)
.
In particular, this makes e(Xi, Ui) realize the upper bound in eq. (6) for   = 1.5 when Ui = 1
and the lower bound otherwise.
We compare the policies learned by a variety of methods. We consider two commonplace
standard methods that assume unconfoundedness: the logistic policy minimizing the IPW
estimate with nominal propensities4 and the direct comparison policy gotten by estimating
CATE using causal forests and comparing it to zero (CF; Wager and Athey 2017b). We
compare these to our methods with a never-treat baseline policy ⇡0(x) = 0: our robust logistic
policy using the unbudgeted uncertainty set, our robust logistic policy using the budgeted
uncertainty set and multipliers ⇢ = 0.5, 0.3, 0.2, and optimal confounding-robust trees of
depth 3. For each of these we vary the parameter   in {0.3, 0.4, . . . , 1.6, 1.7, 2, 3, 4, 5}. For
logistic policies, we run 15 random restarts of Alg. 1 with a step-schedule of  = 0.5 and
return the one with the best robust objective value, unless the best robust objective value
is positive, in which case we just return ⇡0, which is feasible. We use Gurobi to solve the
OCRT problem and set a time limit of 400 seconds for each solve.
For each of 50 replications, we generate an observational dataset of n = 200 according to
the above model, run each of the above mentioned methods to learn a policy, and compute the
true value of each learned policy (by using the known counterfactuals, which we generated).
We report the value as the regret relative to the value of ⇡0. We plot the results in Fig. 2,
showing the mean regret over replications along with the standard error (shaded regions).
Both the methods that assume unconfoundedness actually learn a policy that is worse
than ⇡0 and that would introduce significant net harm if used in its place. By construction,
for   very small (left end of plot), our methods do not induce any robustness, assuming
that true propensities are falsely similar to nominal, and the policy we learn matches the
performance of the standard methods (IPW and CF) and similarly incurs some regret relative
to control. When we add robustness, our policies achieve substantial improvements. As  
increases (middle of plot), the learned robust logistic policies are able to achieve negative
regret, meaning we improve upon ⇡0. As   grows very large (right end of plot), we are
very robust to any size of confounding and almost always default to ⇡0 as a policy that
ensures never doing worse and our true regret converges to 0. Even in this extreme example
of confounding where the true propensities achieve the odds-ratio bounds, the budgeted
4We also tried the self-normalized variant of Swaminathan and Joachims (2015a) and report the results in
Sec. C in the appendix.
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Table 1: Best regret achieved by policies on synthetic example
R⇡0(⇡)  
⇤
IPW 0.22 (0.06) –
CF 0.18 (0.01) –
OCRT  0.09 (0.03) 1.5
CRLogit.  0.28 (0.03) 1.5
CRLogit. L1 0.5  0.38 (0.04) 1.5
CRLogit. L1 0.3  0.34 (0.04) 1.5
CRLogit. L1 0.2  0.43 (0.03) 1.5
version is able to attain similar improvements to the unbudgeted version for ⇢ = 0.3, 0.2, and
uniformly better improvements for ⇢ = 0.5. These improvements are relatively insensitive to
the exact value of ⇢ and the budgeted version is able to achieve improvement even when the
budgeted uncertainty set is misspecified. In this example, OCRT suffers from the fact that
the generation process we defined follows a linear non-axis-aligned structure, making it hard
for a shallow tree to capture the effect heterogeneity. Specifically, the optimal policy in this
setting is a linear policy which may be poorly approximated by an axis-aligned decision-tree
policy. In real data, as in the example in the next section, trees usually fare better. In
Table 1, we summarize the results for the best parametric policies found in this case. The
best improvements for the parametric policies are achieved at   = 1.5, consistent with the
model specification.
7.2 Assessment with Clinical Data: International Stroke Trial
We next build an evaluation framework for our methods from real-world clinical data, where
the counterfactuals are not known, by using a large randomized clinical trial, creating a
training set that is confounded by healthy user bias and evaluating on a test dataset using
unbiased estimation based on known, constant treatment arm randomization probabilities.
Specifically, we study data from the International Stroke Trial (IST), which assessed
the clinical effectiveness of aspirin, subcutaneous heparin, both, or neither among 19,435
patients with acute ischaemic stroke in a factorial experimental design. We focus on the
aspirin and heparin (high dose) (T = 1) vs. only aspirin (T =  1) treatment arms from the
original factorial design, numbering 7,233 cases with P (T = 1) = 1/3 (International Stroke
Trial Collaborative Group 1997). Findings from the study suggest a clear reduction in adverse
events (recurrent stroke or death) from aspirin, whereas heparin efficacy is inconclusive since
the small and non-significant benefit on rates of death at 6 months was offset by greater
incidence of other adverse events such as hemorrhage or cranial bleeding.
The original trial measured a set of clinical outcomes including death, stroke recurrence,
adverse effect, and recovery at various endpoints. We scalarize these clinical outcomes,
penalizing adverse effects while recognizing the benefits of recovery, and summarize clinical
outcomes in the following composite loss function:
Y = 2I[death] + I[recurrent stroke] + 0.5I[pulmonary embolism or intracranial bleeding]
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Figure 3: Out-of-sample policy regret for IST, estimated from RCT data
+0.5I[other side effects]  2I[full recovery at 6 months]  I[discharge within 14 days]
We construct an evaluation framework from the dataset by splitting off from the data
a held-out test set and subsampling from the remaining patients in order to construct the
confounded training data, which is then used to train personalized treatment assignment
policies. To subsample the training data, we first choose each unit for inclusion with
independent probability 0.6 + 0.3Xage, where Xage 2 [0, 1] is rescaled. Then, to introduce
confounding that follows the healthy user bias pattern, among the selected treated patients
we censor those with the worst 10% of outcomes and, similarly, we censor the 10% best
patients in the control group. Such unobserved confounding generates a training dataset
where heparin appears to lead to better outcomes. While the ATE estimate from the full data
is ⌧ = 0.14 (significant), the difference in means between treated and control outcomes in the
censored data is ⌧ =  0.29 (significant). Fitting an interacted linear model on the full-data
suggests that treatment effects are heterogeneous with statistically significant interaction
with such covariates as indicator of stroke subtype being “PACS,” lack of brainstem/cerebellar
signs, visible infarct on CT, and lack of face deficit, and symptoms noted on waking.
Given only the training data, we train treatment assignment policies that are personalized
based on the recorded covariates available at the time of randomization. These covariates
include age, indicators of conscious state, biological sex, blood pressure, and factors describing
clinical assessments such as visible infarct on CT, arm/face deficit, leg/foot deficit, dysphasia,
hemianopia, stroke subtype, visuospatial disorder, brainstem/cerebellar signs, and other
deficit. We construct one-hot encodings of the categorical variables and train policies on 28
covariates after the dummy encoding. (Some covariates have categorical levels of “Yes,” “No,”
or “Can’t Assess”.)
We again compare our approach to two standard methods that assume unconfoundedness:
IPW and CF. We compare these to our confounding-robust approaches with logistic assignment
policies using unbudgeted uncertainty (CRLogit) and budgeted uncertainty with parameter
⇢ = 0.5 (CRLogit.L1) and with the optimal confounding-robust tree-based policy (OCRT).
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(a) % of patients with ⇡(X) > 0.5 (b) Avg prognosis among patients with ⇡(X) >
0.5
Figure 4: Comparison of policy behavior on IST data as   varies
We let nominal propensities be given by eˆ(Xi) = 0.2 + 0.1Xi,age. We use the same algorithm
parameters as in the last section.
Without access to the true counterfactual outcomes for patients, we evaluate the perfor-
mance of policies out of sample by using an unnormalized Horvitz-Thompson estimator on
the held-out truly-randomized data from the clinical trial. For the out-of-sample evaluation
we use Horvitz-Thompson rather than Hájek because it is unbiased and therefore allows for a
fair comparison of different methods. In the RCT, the probabilities of completely randomized
treatment assignment, as reported above, are p 1 = 23 and p1 =
1
3
. Correspondingly, our
out-of-sample estimate of policy regret relative to ⇡0(x) = 0 based on the held-out dataset
Stest is given by
Rˆtest⇡0 (⇡) =
1
|Stest|
X
i2Stest
YiTi⇡(Xi)
1
pTi
We run 10 replications, in each of which we construct a random train-test split, subsample
the training data as described above, train the various personalized policies, and evaluate
them out of sample on the test data. We plot resulting mean regret over replications (along
with standard error) in Fig. 3. We see first of all that the standard approaches to policy
learning introduce significant harm relative to the aspirin-only baseline. In this example,
the harm is real, corresponding to deaths and adverse health effects and highlighting the
dangers of unchecked policy learning and the impediments to the implementation of standard
methods. As before, by construction, for   very small (left end of plot) our policies perform
similarly to methods that assume unconfoundedness. As   increases, our methods achieve
significant policy improvement. The logistic unbudgeted policy (CRLogit) achieves the best
average test performance of  0.14 at   = 0.4. For     0.9, the robust optimization objective
is not able to find a policy that so-uniformly improves upon control and returns ⇡0, which
of course induces no harm. The logistic budgeted policy (CRLogit.L1) achieves the best
estimated improvement of  0.22 at   = 0.5. As   increases, the budgeted policy finds a
policy estimated to do well, although it treats very few people, as we discuss in the next
comparisons. The optimal confounding-robust trees (OCRT), in optimizing over the space
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Table 2: Policy regret assessed within subgroups
IPW, CF CRLogit CRLogit.L1 OCRT % Pop
Age > median +0.07 (0.01)  0.12 (0.02)  0.18 (0.04)  0.07 (0.04) 50.00
Age < median +0.29 (0.01)  0.20 (0.03)  0.28 (0.03)  0.19 (0.04) 50.00
Resting Bld. Press. > median +0.04 (0.01)  0.11 (0.03)  0.21 (0.03)  0.10 (0.03) 50.00
Resting Bld. Press. < median +0.06 (0.01)  0.19 (0.02)  0.24 (0.04)  0.14 (0.04) 50.00
Conscious state (Fully alert) +0.06 (0.04)  0.12 (0.03)  0.22 (0.02)  0.14 (0.03) 76.41
Conscious State (Unconscious) +0.09 (0.13)  0.30 (0.16)  0.38 (0.24)  0.16 (0.24) 1.33
Sex (M) +0.07 (0.02)  0.16 (0.03)  0.24 (0.03)  0.15 (0.04) 52.63
Sex (F)  0.16 (0.02)  0.13 (0.02)  0.20 (0.04)  0.10 (0.04) 47.37
Symptoms on waking (Y) +0.03 (0.02)  0.14 (0.02)  0.20 (0.03)  0.12 (0.04) 29.18
Symptoms on waking (N) +0.99 (0.06)  0.17 (0.03)  0.23 (0.04)  0.13 (0.04) 70.82
Atrial fibrillation (Y) +0.00 (0.02)  0.18 (0.03)  0.20 (0.07)  0.08 (0.06) 16.97
Atrial fibrillation (N) +0.05 (0.02)  0.15 (0.03)  0.23 (0.03)  0.13 (0.03) 83.03
Infarct visible on CT (Y) +0.03 (0.00)  0.14 (0.02)  0.22 (0.05)  0.10 (0.05) 33.55
Infarct visible on CT (N) +0.07 (0.02)  0.16 (0.03)  0.23 (0.03)  0.14 (0.03) 66.45
Face deficit (Y) +0.04 (0.00)  0.12 (0.02)  0.21 (0.04)  0.11 (0.04) 72.49
Face Deficit (N) +0.11 (0.05)  0.17 (0.05)  0.24 (0.04)  0.16 (0.04) 26.28
Arm/hand deficit (Y) +0.05 (0.01)  0.12 (0.02)  0.21 (0.04)  0.11 (0.04) 85.37
Arm/hand deficit (N) +0.08 (0.06)  0.23 (0.08)  0.30 (0.06)  0.17 (0.06) 14.08
Leg/foot deficit (Y) +0.05 (0.00)  0.11 (0.02)  0.19 (0.04)  0.10 (0.04) 75.05
Leg/foot deficit (N) +0.07 (0.06)  0.22 (0.07)  0.34 (0.04)  0.22 (0.05) 23.68
Dysphasia(Y) +0.03 (0.00)  0.13 (0.03)  0.21 (0.05)  0.10 (0.04) 43.65
Dysphasia (N) +0.08 (0.03)  0.14 (0.03)  0.24 (0.02)  0.14 (0.03) 53.36
Hemianopia(Y) +0.05 (0.02)  0.09 (0.03)  0.17 (0.07)  0.04 (0.05) 15.71
Hemianopia (N) +0.06 (0.04)  0.13 (0.04)  0.24 (0.01)  0.16 (0.03) 63.56
Visuospatial disorder(Y) +0.05 (0.02)  0.10 (0.04)  0.16 (0.06)  0.04 (0.05) 16.67
Visuospatial disorder(N) +0.07 (0.04)  0.13 (0.03)  0.24 (0.02)  0.16 (0.03) 65.75
Brainstem/cerebellar signs (Y) +0.08 (0.03)  0.20 (0.03)  0.24 (0.06)  0.04 (0.09) 10.59
Brainstem/cerebellar signs (N) +0.06 (0.02)  0.12 (0.02)  0.21 (0.03)  0.13 (0.03) 81.12
Other deficit (Y) +0.15 (0.02)  0.12 (0.03)  0.16 (0.06)  0.02 (0.07) 6.44
Other deficit (N) +0.04 (0.02)  0.13 (0.02)  0.22 (0.03)  0.13 (0.03) 87.01
Stroke subtype (Other)  0.02 (0.09) +0.05 (0.16) +0.14 (0.21) +0.46 (0.19) 0.30
Stroke subtype(PACS) +0.07 (0.02)  0.10 (0.04)  0.16 (0.01)  0.13 (0.03) 40.97
Stroke subtype (POCS) +0.06 (0.03)  0.20 (0.03)  0.24 (0.06)  0.03 (0.09) 11.09
Stroke subtype (TACS) +0.03 (0.04)  0.14 (0.06)  0.21 (0.10)  0.04 (0.09) 24.04
of constant-probability trees of maximum depth 3, achieve the best performance of around
 0.12 at   = 0.5. Although OCRT does not do better than the logistic policies, it offers
similar performance with an exceedingly simple and highly interpretable policy, which is an
important feature in clinical decision making.
In Figs. 4a and 4b, we further study the behavior of the different policies to understand
these differences in performance. The former shows how many patients are targeted for
treatment and the latter shows the prognosis score among those targeted for treatments.
The IST trial recorded a prognosis score of predicted probability of death at 6 months using
an externally validated model. Because this model uses the same covariates as the ones
observed and used to derive the personalization, we do not include the score as an independent
covariate for policy learning, but now consider this score to assess the validity of our robust
policy as an externally validated indicator of patient severity. Fig. 4a shows that the standard
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methodologies over-intervene with aggressive heparin treatment, which explains their bad
performance in practice. Our robust policies carefully target whom to treat, or, for very large
 , treat no one. Fig. 4b helps us understand who are the patients that our policies picked
out for more aggressive treatment. We see that our policies target patients with overall
larger-than-average prognosis score, indicating that our policies are learning and treating on
appropriate indicators of severity from the available covariates. Note that the standard errors
in Fig. 4b get larger for larger   because fewer are treated. (And, for sufficiently large  ,
CRLogit treats no one so its curve ends.) Though the robust budgeted policy (CRLogit.L1)
obtains a very slightly negative objective value for   > 0.9, we see that the resulting treatment
policy treats very few and only the most severe patients. Our learned policies suggest that
improvements from heparin may be seen in the highest-risk patients, consistent with the
findings of Berge and Sandercock (2002). After a systematic review comparing anticoagulants
such as heparin against aspirin, Berge and Sandercock (2002) conclude from a study of trials
including IST that heparin provides little therapeutic benefit, with the caveat that the trial
evidence base is lacking for the highest-risk patients where heparin may be of benefit. Thus,
our robust method appropriately treats those, and only those, who stand to benefit from the
more aggressive treatment regime.
In Table. 2 we decompose the policy regret by subgroup, showing the average within-
subgroup regret as well as the percentage that the group comprises of the population. We
compare IPW and CF with the best policies found by our methods. This allows us to see
which groups each policy may be helping and which it may be hurting. (Note that some
percentages do not add up as there may be a third category such as “Can’t Assess.”) We
find that the improvement from our treatment policies is generally achieved uniformly for
all subgroups, except for the subgroup of “Stroke Type: Other,” which is rare with only 22
individuals of that subtype in the whole dataset. Thus, although the guarantee only ensures
a net improvement, we find that almost every subgroup benefits from our precise-yet-safe
targeting. Both IPW and CF learn the treat-all policy, which induces harm for almost all
subgroups.
8 Conclusion
In this paper, we addressed the problem of learning personalized intervention policies from
observational data with unobserved confounding. Standard methods can be corrupted by
this confounding and lead to harm compared to current standards of care, a concern of
utmost importance in sensitive applications such as medicine, public policy, and civics. We
therefore develop a framework for confounding-robust policy improvement, which optimizes
personalization policies in view of possible unobserved confounding in observational data,
allowing for more reliable and credible policy evaluation and learning. Our approach optimizes
the minimax regret achieved by a candidate personalized decision policy against a baseline
policy. We generalize the class of IPW-based estimators and construct uncertainty sets
centered at the nominal IPW weights that can be calibrated by approaches for sensitivity
analysis in causal inference. A future line of investigation is a confounding-robust variant
based on the doubly robust estimator of policy value.
We prove a strong statistical guarantee that, if the uncertainty set is well-specified, our
27
approach is guaranteed to do no worse than the standard of care so that it can be safely
implemented, and possibly offer improvement if the data can support it. Specifically, the result
proved a finite-sample guarantee that can be checked. We leverage the optimization structure
of weight-normalized estimators of the policy value to perform policy optimization efficiently
by subgradient descent on the robust risk, or optimizing over the space of decision trees.
Assessments on synthetic and clinical data demonstrate the benefits of confounding-robust
policy improvement, which can recommend personalized treatment while maintaining strong
guarantees on performance relative to baseline preferences.
These tools allow an analyst to find reliable and personalized policies that can safely
offer improvements even if there is unobserved confounding and to assess the implications of
different plausible levels of confounding on the performance of a robust personalized decision
policies. We believe this development is absolutely crucial for the practical adoption of
algorithms for personalization that work on the ever growing repositories of observational
data, which are the future of algorithmic decision making due to their size and richness.
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Appendix
A Proofs
Proof. Proof of Lemma 1. Notice that:
P (T = 1 | X) = P (T = 1 | ✏ = 1, X)P (✏ = 1 | X) + P (T = 1 | ✏ =  1, X)P (✏ =  1 | X)
= P (T = 1 | ✏ = 1, X)P (✏ = 1) + P (T = 1 | ✏ =  1, X)P (✏ =  1)
=
✓
I [X  0] + sign(X)
8✓
◆
✓ +
✓
I [X  0] + sign(X)
8(1  ✓)
◆
(1  ✓)
= I [X  0] + sign(X)
4
= I [X  0] 3
4
+ I [X   0] 1
4
Whenever T sign(X) =  1, we have Y = TX. Consequently, for t sign(x) =  1, the joint
distribution of Y, T,X follows the factorization
f(Y = tx, T = t,X = x) = P (T = t | X = x) f (X = x) = P (T = t | X = x) ,
which as shown above is independent of ✓. Whenever t sign(x) = 1, we have Y = TX + 3.6✏.
Consequently, for t sign(x) = 1,the joint distribution of Y, T,X follows the factorization
f(Y = tx+ 3.6y, T = t,X = x) = P (T = 1 | X = x, ✏ = y)P (✏ = y | X = x) f(X = x).
It follows that the distribution of the observed data Y, T,X, is as follows:
f (Y = 3.6y + tx, T = t,X = x) =
8<:
1/8f(x) t sign(x) = 1
3/4f(x) t sign(x) =  1, y = 0
0 otherwise
which is independent of ✓.
Proof. Proof of Theorem 1. Let Z = 1
n
Pn
i=1W
⇤
i . Since W ⇤i 2 [0, ⌫ 1] and EW ⇤i = 2,
Hoeffding’s inequality gives
P (|Z   2|   ✏)  2 exp( 2✏2⌫2n). (17)
Note that if |z   2|  ✏  1 then |z   2| /z  |z   2|  ✏. Therefore, by eq. (17), if
p1 2 [0, 1] is such that 1⌫
q
log(2/p1)
2n
 1, then, with probability at least 1   p1, we have
|Z   2| /Z  1
⌫
q
log(2/p1)
2n
as well as 2
Z
 2.
Let ⇡CR(x) = 1/2 be the complete randomization policy so that
Rˆ⇤⇡CR(⇡) =
2
Z
1
n
nX
i=1
1
2
W ⇤i Ti(2⇡(Xi)  1)Yi.
Note that
R⇡0(⇡)  Rˆ⇤⇡0(⇡) =  (Rˆ⇤⇡CR(⇡) R⇡CR(⇡)) + (Rˆ⇤⇡CR(⇡0) R⇡CR(⇡0))
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Moreover, note that for any ⇡,
|R⇡CR(⇡)| 
1
2
E |W ⇤Y |  1
2
⌫ 1
p
µ2 +  2
Consequently, for any ⇡,   Rˆ⇤⇡CR(⇡) R⇡CR(⇡)     2Z
      1n
nX
i=1
1
2
W ⇤i Ti(2⇡(Xi)  1)Yi  R⇡CR(⇡)
     + |Z   2|Z |R⇡CR(⇡)|
 2
Z
      1n
nX
i=1
1
2
W ⇤i Ti(2⇡(Xi)  1)Yi  R⇡CR(⇡)
     + |Z   2|2Z ⌫ 1pµ2 +  2.
Let fi(⇡) = 12W
⇤
i Ti(2⇡(Xi)  1)Yi, F(X1:n) = {(f1(⇡), . . . , fn(⇡)) : ⇡ 2 F}, and
M = sup
⇡2F
     
nX
i=1
fi(⇡) R⇡CR(⇡)
      ,
L = sup
⇡2F
     
nX
i=1
✏ifi(⇡)
      = supf2F(X1:n)
⌦
✏, f
↵
,
for ✏i being iid Rademacher random variables taking values ±1 equiprobably independent
of all else. Because Efi(⇡) = R⇡CR(⇡), by Pollard (1990, Thm 2.2.), for any   convex and
increasing, we have that
E (M)  E (2L). (18)
Note that for any ⇡, |fi(⇡)|  Fi = 12W ⇤i |Yi|, so that that F forms an envelope on the process
f(⇡). Let D = (W ⇤1:n, T1:n, X1:n, Y1:n) denote all the data. By Pollard (1990, Thm. 3.5),
E✏
⇥
exp(L2/J2) | D⇤  5 for J = 9 kFk2 Z 1
0
q
log(D(kFk2 ⇣,F(X1:n)))d⇣, (19)
where D(⇣, S) for S ⇢ Rn is the minimal number of ⇣-`2-balls needed to cover S. By Pollard
(1990, Cor. 4.10) (see also Haussler 1995),
log(D(kFk2 ⇣,F(X1:n)))  v(log(1/⇣2) + log(2) + 1) + log(v + 1) + 1
and hence
J  36pv kFk2 . (20)
Using the fact that 2L/C  J2/C2 + L2/J2 for any C > 0, we have from eqs. (18) and (19)
that
E exp(M/C)  E exp(2L/C)  E ⇥exp(J2/C2)E✏ ⇥exp(L2/J2) | D⇤⇤  5E exp(J2/C2).
Next, from eq. (20), we have that
E exp(J2/C2)  E exp
 
324v
C2
nX
i=1
(W ⇤i Yi)
2
!
=
nY
i=1
E exp
✓
324v
C2
(W ⇤i Yi)
2
◆
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
nY
i=1
E exp
✓
324v
C2⌫2
Y 2i
◆

nY
i=1
exp
✓
648v
C2⌫2
(EYi)2
◆
E exp
✓
648v
C2⌫2
(Yi   EYi)2
◆
Now, note that as long as a = 648v
C2⌫2
 c/2 where c = 1
2 2
, then by subgaussianity, we
have that E exp (a(Yi   EYi)2)  1 + 2ac a  1 + 4ac . Letting C =
18
p
2v
p
n
p
µ2+8 2
⌫
p
log(↵)
so that
a = log↵/(n(µ2 + 8 2)), we get that, as long as n   4 log(↵)/(µ2/ 2 + 8),
E exp(J2/C2)  exp
✓
log↵
µ2 + 8 2
µ2
◆✓
1 +
4 log↵
cn(µ2 + 8 2)
◆n
 exp
✓
log↵µ2
µ2 + 8 2
◆
exp
✓
8 log↵ 2
µ2 + 8 2
◆
= ↵.
Set ↵ = exp(2). Then, as long as n   8/(µ2/ 2 + 8), E exp(M/C)  10 and hence
P
✓
1
n
M > ✏
◆
 5 exp(2) exp n✏/C = 37 exp
 
  ✏
p
n⌫
18
p
v
p
µ2 + 8 2
!
,
whence, as long as n   8/(µ2/ 2 + 8), with probability at least 1  p2, we have
1
n
M  18
p
v
p
µ2 + 8 2 log(37/p2)
⌫
p
n
.
Letting p1 = 2 /39 and p2 = 37 /39, we find that as long as n   max
⇣
log(39/ )
2⌫2
, 8
µ2/ 2+8
⌘
, we
have that with probability at least 1   , sup⇡2F(R⇡0(⇡)  Rˆ⇤⇡0(⇡)) is bounded above byp
log(39/ )(µ2 +  2)
⌫2
p
2n
+
72
p
v
p
µ2 + 8 2 log(39/ )
⌫
p
n
 73
p
v
p
µ2 + 8 2 log(39/ )
⌫2
p
n
Next, note that by assumption (W ⇤1 /t, . . . ,W ⇤n/t) 2 U for some t > 0. Therefore,
Rˆ⇤⇡0(⇡) =
2
Pn
i=1W
⇤
i (⇡(Xi)  ⇡0(Xi))TiYiPn
i=1W
⇤
i
=
2
Pn
i=1W
⇤
i /t(⇡(Xi)  ⇡0(Xi))TiYiPn
i=1W
⇤
i /t
 R⇡0(⇡;U),
which completes the proof.
Proof. Proof of the equivalence of programs (12) and (13). We can easily verify that a feasible
solution for one problem is feasible for the other: for a feasible solution W to (FP), we can
generate a feasible solution to (LP) as wi = WiP
iWi
, t = 1P
iWi
with the same objective value.
In the other direction, we can generate a feasible solution to (13) from a feasible fractional
program (12) solution W, t if we take wi = wit. This solution has the same objective value
since
P
iwi = 1.
Proof. Proof of Thm. 2. We analyze the program using complementary slackness, which will
yield an algorithm for finding a solution that generalizes that of Aronow and Lee (2012).
At optimality only one of the weight bound constraints, for nontrivial bounds a , b ,
wi  bi or ai  wi will be tight. For the nonbinding primal constraints, by complementary
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slackness the corresponding dual variable ui for constraint a i  wi or v i for wi  bi will be
0. Thus, a total of n+ 1 constraints are tight in the dual (since t > 0 and the constraint is
not binding), including the constraint
P
i bivi + aiui   0. So the optimal solution to the
dual will satisfy:
min 
s.t.     ri + ui   vi, 8i 2 1, . . . , nX
i
 b i vi + a i ui = 0
Note that ui > 0 if Yi <   and vi > 0 if Yi >  . Then at optimality, there exists some index
(k) (where (k) refers to the kth index of the increasing order statistics, an ordering where
r(1)  r(2)  · · ·  r(n).
We can subsitute in the solution from the binding constraints   = ri + ui   vi and obtain
the following equality which holds at optimality:X
i:(i)<(k)
a (i)(   r(i)) 
X
i:(i) (k)
b (i)(r(i)    ) = 0X
i:(i)<(k)
a (i) +  
X
(i)>(k)
b (i) =
X
i:(i) (k)
b (i)r(i) +
X
i:(i)<(k)
a (i)r(i)
 (k) =
P
i:(i)<(k)
a (i)r(i) +
P
i:(i) (k)
b (i)r(i)P
i:(i)<(k)
a (i) +
P
i:(i) (k)
b(i)
We discuss how to derive the corresponding feasible primal solution from the dual
solution: for r(i), take w(i) =
a 
(i)
I{(i)k}+b 
(i)
I{(i)>k}P
i:(i)<(k)
a 
(i)
+
P
i:(i) (k)
b 
(i)
and t =
P
i:(i)<(k)
a (i) +
P
i:(i) (k)
b (i). Thus by
complementary slackness,   is the optimal value with the corresponding optimal solution
exhibited above. Therefore, we need only check the possible objective value  (k) for k =
1, . . . , n.
The optimal such   occurs with the order statistic threshold at (k) for k⇤ = inf{k =
1, . . . , n+ 1 :  (k + 1) <  (k)}. Consider the parametric restriction of the primal program,
parametrized by the sum of weights t; the value function is concave in t and furthermore
concave in the discrete restriction of t to the values it takes at the vertex solutions.
B Recursive Partitioning: MIP Warm Start
We provide a heuristic recursive-partitioning based scheme for optimizing policy risk over the
space of limited-depth decision trees recursively, analogous to CART’s recursive partitioning
approach (Breiman et al. 1984). Such an approach is used to obtain a warm start for the
MIaP of the optimal confounding-robust tree. The algorithm initializes by assigning the same
treatment ⌧0 to all, and iteratively refines the treatment assignment by recursive partitioning,
seeking univariate splits which minimize the minimax risk. The candidate split threshold for
each covariate is determined by iteratively re-evaluating the minimax risk for incremental
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Algorithm 2 Greedy Recursive Partitioning (Partition)
1: Input: partition SL,l = {(Xi1 , Ti1 , Yi1)}, depth  , preliminary assignment ⌧  1 2 [m]n
2: for d 2 [p] do (find best partition index):
3: [i] Get the sorted indices of ({Xi,d})
4: i⇤j , v
⇤
j  Find the best dimension and threshold to split xj⇤ < xi⇤j ,j⇤
5: i⇤j,rev, v
⇤
j,rev  Find the best dimension and threshold to split xj⇤ > xi⇤j ,j⇤
6: j⇤  argminj i⇤j , i⇤  i⇤j⇤ , ✓⇤  X(i⇤),j⇤+X(i⇤+1),j⇤2
7: ⇡(X)  xj⇤  ✓⇤ if v⇤j < v⇤j,rev else xj⇤   ✓⇤
8: if (continue recursing) then:
9: SL  X[0:i⇤], SR  X[i⇤:|S|]
10: update ⌧0, the candidate treatment assignment
11: ⇧ˆL  Partition(SL, ⌧ 0, + 1), ⇧ˆR  Partition(SR, ⌧0, + 1)
return (⇡(X) , ⇧ˆL, ⇧ˆR )
changes to the policy, maintaining the invariant that the base policy is set by the leaves above
a node in the tree. Using specialized data structures such as B-trees allows for O(log(N))
efficient updates for maintaining and updating the sorted list of multipliers YiTi(⇡i  ⇡0), and
manipulating pre-computed cumulative sums of the initial sorted order allows for efficient
re-computation of the optimization solution. We note that such an approach is possible only
for the unbudgeted uncertainty set U n , since incorporating the uncertainty budget would
couple the risk across tree levels.
In comparison to other approaches using tree-based approaches for estimating causal
effects (Wager and Athey 2017b) or for personalization (Kallus 2017a), which consider splits
based on impurities related to the expected mean squared error of causal effects on a separate
sample of data from that used to estimate the causal effects within leaves, or determine the
optimal treatment, our recursive partitioning heuristic simultaneously determines the partition
and the policy treatment assignment within the partition. In making greedy splits, changes in
the objective function are assessed as a result of changing the policy assignment within SL,l,
and the optimal split location and sense (I[a|X < b] or I[a|X > b]) are determined by changes
in the policy assignment within SL,l. However, in general, the optimal such policy assignment,
determined incrementally from the assignments {SL 1,l}l2TL , depends additionally on the
assigned policy for other nodes at the same level as well.
C Additional Experimental Details
In the simulated example in Sec. 7.1 and the example on IST data in Sec. 7.2, we additionally
assess the performance of a self-normalized counterfactual policy maximizer, SNPOEM
(Swaminathan and Joachims 2015a). This approach adds both a variance regularization and
a self-normalization, both of which strongly bias the learned policy toward the logging policy.
While this has merit, it results in spuriously inconsistent results across the problems we
consider, where in one it has reasonable results and in another much worse results than any
other standard method. Specifically, SNPOEM achieves a mean policy value of 0.82 (SD 0.04)
in the simulated example and 0.04 (SD 0.029) in the IST example. Because this additional
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layer of complexity only confuses the comparisons and the main focus on the contrast between
ignoring and accounting for unconfoundedness, we omit these results from the main text.
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